Showing results (71-80 of 166) with videos related to
Sort By:
Pageof 17
Journal of the National Cancer Institute|October 5, 1988
Regression models in clinical studies: determining relationships between predictors and responseF E Harrell, K L Lee, B G PollockThe American Journal of Psychiatry|November 1, 1992
Impact of psychiatric hospitalization on behavioral complications of Alzheimer's diseaseG S Zubenko, J Rosen, R A Sweet, et al.Anxiety|January 1, 1996
Comorbid anxiety disorders in late-life depressionB H Mulsant, C F Reynolds, M K Shear, et al.Journal of Chromatography. B, Biomedical Applications|June 23, 1995
Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detectionJ P Foglia, D Sorisio, M A Kirshner, et al.The Journal of Clinical Psychiatry|August 11, 2000
Use of electroconvulsive therapy in a state hospital: a 10-year reviewA P Sylvester, B H Mulsant, K N Chengappa, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|May 23, 1997
Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detectionJ P Foglia, D Sorisio, M Kirshner, et al.The American Journal of Psychiatry|October 27, 1997
Mortality of elderly patients with psychiatric disordersG S Zubenko, B H Mulsant, R A Sweet, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|April 21, 1998
Determinants of spontaneous extrapyramidal symptoms in elderly psychiatric inpatients diagnosed with Alzheimer's disease, major depressive disorder, or psychotic disordersR A Sweet, M Akil, B H Mulsant, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 2, 2001
Treatment outcome in suicidal vs. non-suicidal elderly patientsK Szanto, B H Mulsant, P R Houck, et al.Psychopharmacology Bulletin|January 1, 1996
Paroxetine is a novel nitric oxide synthase inhibitorM S Finkel, F Laghrissi-Thode, B G Pollock, et al.Pageof 17